With biopharmaceuticals dominating the drug development landscape, Thermo Fisher Scientific says it needs more capacity throughout its manufacturing network. To that end, its CDMO operations will ...

As layoffs continue to roil the biotech industry, bigger drugmakers and manufacturers such as Bristol Myers Squibb and Emergent BioSolutions haven’t been immune. Now, Thermo Fisher Scientific is among ...

In an effort to expand its pharmaceutical services footprint internationally, Thermo Fisher Scientific Inc. TMO signed a definitive agreement with GlaxoSmithKline plc GSK to acquire a drug substance ...

Thermo Fisher Scientific Inc. TMO recently closed the acquisition of a drug substance manufacturing site of GlaxoSmithKline plc GSK in Cork, Ireland much ahead of schedule. Valued at 90 million euros, ...

A technician uses a pipette to fill test tubes at the U.S. Precision Medicine Science Center in Cambridge, Massachusetts. A Thermo Fisher Scientific plant in western Orange County will manufacture ...

As Thermo Fisher’s Jennifer Cannon explains in this first part of a two-part interview, the collaboration is intended to help ...

The completion of the acquisition is anticipated by mid-2026, pending the satisfaction of customary closing conditions.

Life sciences group Thermo Fisher has sealed an all-cash takeover of drug trial software maker Clario in a deal that values ...

The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.

Thermo Fisher Scientific shares rise after announcing $8.875B acquisition of Clario, enhancing AI-powered clinical trials and ...

The initiative reflects the PPD business’ vision to promote sustainability throughout the clinical development ecosystem.

Thermo Fisher Scientific (NYSE:TMO) has confirmed a deal to acquire clinical trial data management firm Clario Holdings from ...